Flowable Hemostats Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2032

6.14%
CAGR (2026-2032)
1.1 USD Bn.
Market Size
305
Report Pages
134
Market Tables

Overview

The Flowable Hemostats Market size was valued at USD 1.10 Billion in 2025 and the total Flowable Hemostats revenue is expected to grow at a CAGR of 6.14% from 2025 to 2032, reaching nearly USD 1.67 Billion by 2032.

The flowable hemostat has flowable quality, which uses in wet or difficult to reach surfaces. It is a surgical tool that is majorly used during minimally invasive surgical procedures to control halt bleeding or blood loss during surgery. It is essentially used in the early phases of surgery for an initial incision that closes blood vessels until ligation. The demand for flowable hemostat is rising in a difficult time of the coronavirus pandemic. The demand for medical devices and medicines are showing a boost from last year.
Flowable Hemostats Market 2025-2032To know about the Research Methodology :- Request Free Sample Report

The government and healthcare workers are actively working, and the healthcare system is facing the challenge caused by the COVID-19. The pharmaceutical and medical device manufacturing companies are providing philanthropic support to the communities. The growth of the market is creating enormous opportunities for new market players. Manufacturing companies are focusing on meeting the demand for medical equipment. Pharmaceutical product manufacturing companies are outsourcing more production to trusted strategic partners. These partnerships will help pharma companies to expand their manufacturing capacity and add new technology, which will increase production and drive market growth over the forecasted period.

The flowable hemostats use porcine or bovine gelatin as a material. Smooth gelatin has an improved in vitro capacity to maintain RBCs and thrombin, which offer superior hemostatic efficacy, greater in vivo blood loss reduction, and superior bleeding control.

By applications, the global flowable hemostats market is segmented into general surgery, cardiac surgery, vascular surgery, neuro & spine surgery, orthopedic surgery, and other application. The neurosurgery and general surgery segment are anticipated to hold the largest market share of xx% in the forecast period. The rising adoption of minimally invasive surgeries and the rise in regulated clinical procedures of old people are driving the market in the forecasted period. Growing demand for minimum invasive spinal surgeries and development in medical technology is driving the market in the last few years.

The global Flowable Hemostats market is segmented into various regions such as North America, Europe, Middle East & Africa, South America, and Asia Pacific. The North America has ledflowable hemostatsmarket in 2025 and is expected to grow at the xx% CAGR during the forecast period. The market is mainly driven by the growing prevalence of accidents and aged population.The development of technologically advanced products are achieving blood control during trauma-related procedures.

The Asia Pacific is anticipated to grow at the xx% CAGR during the forecast period thanks to increasing number of surgeries, chronic condition, technological advancements, and improvement in healthcare facilities.

The report covers an in-depth analysis of key development, marketing strategies, supply-side and demand-side indicators, and company profiles of market leaders, potential players, and new entrants. Key players operating in this market are adopted various organic and inorganic growth strategies such as mergers & acquisitions, joint ventures, collaborations, expansion, new product launches, and patents to increase their regional presence and business operations.

The objective of the report is to present a comprehensive analysis of the Global Flowable Hemostats Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report.

External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Flowable Hemostats Market dynamics, structure by analyzing the market segments and project Global Flowable Hemostats Market Clear representation of competitive analysis of key players by price, financial position, Product portfolio, growth strategies, and regional presence in the Global Flowable Hemostats Market the report investor’s guide.

Flowable Hemostats Market Scope: Inquire before buying

Flowable Hemostats Market
Report Coverage Details
Base Year: 2025 Forecast Period: 2026-2032
Historical Data: 2020 to 2025 Market Size in 2025: USD 1.10 Bn.
Forecast Period 2026 to 2032 CAGR: 6.14% Market Size in 2032: USD 1.67 Bn.
Segments Covered: by Application General Surgery
Cardiac Surgery
Vascular Surgery
Neuro & Spine Surgery
Orthopedic Surgery
Other Application
by Material Porcine Gelatin
Bovine Gelatin
by End User Hospitals
Clinics
Ambulatory Surgical Centers

Flowable Hemostats Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)

Flowable Hemostats Market, Key players are:

1.Johnson & Johnson
2.Baxter International
3.Teleflex Incorporated
4.CR Bard, Inc.
5.Ethicon, Inc.
6.Braun Melsungen AG
7.Integra LifeSciences
8.Marine Polymer Technologies, Inc.
9.Pfizer, Inc.
10.Z-Medica LLC
11.Gelita Medical GmbH

Frequently Asked Questions:

1. Which region has the largest share in Global Flowable Hemostats Market?
Ans: Asia Pacific region held the highest share in 2025.

2. What is the growth rate of Global Flowable Hemostats Market?
Ans: The Global Flowable Hemostats Market is growing at a CAGR of 6.14% during forecasting period 2026-2032.

3. What is scope of the Global Flowable Hemostats market report?
Ans: Global Flowable Hemostats Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Flowable Hemostats market?
Ans: The important key players in the Global Flowable Hemostats Market are – Johnson & Johnson, Baxter International, Teleflex Incorporated, CR Bard, Inc., Ethicon, Inc., Braun Melsungen AG, Integra LifeSciences, Marine Polymer Technologies, Inc., Pfizer, Inc., Z-Medica LLC, and Gelita Medical GmbH.

5. What is the study period of this market?
Ans: The Global Flowable Hemostats Market is studied from 2025 to 2032.

Table of Contents

Global Flowable Hemostats Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Flowable Hemostats Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Flowable Hemostats Market Analysis and Forecast 6.1. Flowable Hemostats Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Flowable Hemostats Market Analysis and Forecast, by Components 7.1. Introduction and Definition 7.2. Key Findings 7.3. Flowable Hemostats Market Value Share Analysis, by Components 7.4. Flowable Hemostats Market Size (US$ Mn) Forecast, by Components 7.5. Flowable Hemostats Market Analysis, by Components 7.6. Flowable Hemostats Market Attractiveness Analysis, by Components 8. Global Flowable Hemostats Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Flowable Hemostats Market Value Share Analysis, by Application 8.4. Flowable Hemostats Market Size (US$ Mn) Forecast, by Application 8.5. Flowable Hemostats Market Analysis, by Application 8.6. Flowable Hemostats Market Attractiveness Analysis, by Application 9. Global Flowable Hemostats Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Flowable Hemostats Market Value Share Analysis, by End User 9.4. Flowable Hemostats Market Size (US$ Mn) Forecast, by End User 9.5. Flowable Hemostats Market Analysis, by End User 9.6. Flowable Hemostats Market Attractiveness Analysis, by End User 10. Global Flowable Hemostats Market Analysis, by Region 10.1. Flowable Hemostats Market Value Share Analysis, by Region 10.2. Flowable Hemostats Market Size (US$ Mn) Forecast, by Region 10.3. Flowable Hemostats Market Attractiveness Analysis, by Region 11. North America Flowable Hemostats Market Analysis 11.1. Key Findings 11.2. North America Flowable Hemostats Market Overview 11.3. North America Flowable Hemostats Market Value Share Analysis, by Application 11.4. North America Flowable Hemostats Market Forecast, by Application 11.4.1. General Surgery 11.4.2. Cardiac Surgery 11.4.3. Vascular Surgery 11.4.4. Neuro & Spine Surgery 11.4.5. Orthopedic Surgery 11.4.6. Other Application 11.5. North America Flowable Hemostats Market Value Share Analysis, by Components 11.6. North America Flowable Hemostats Market Forecast, by Components 11.6.1. Porcine Gelatin 11.6.2. Bovine Gelatin 11.7. North America Flowable Hemostats Market Value Share Analysis, by End User 11.8. North America Flowable Hemostats Market Forecast, by End User 11.8.1. Hospitals 11.8.2. Clinics 11.8.3. Ambulatory Surgical Centers 11.9. North America Flowable Hemostats Market Value Share Analysis, by Country 11.10. North America Flowable Hemostats Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Flowable Hemostats Market Analysis, by Country 11.12. U.S. Flowable Hemostats Market Forecast, by Application 11.12.1. General Surgery 11.12.2. Cardiac Surgery 11.12.3. Vascular Surgery 11.12.4. Neuro & Spine Surgery 11.12.5. Orthopedic Surgery 11.12.6. Other Application 11.13. U.S. Flowable Hemostats Market Forecast, by Components 11.13.1. Porcine Gelatin 11.13.2. Bovine Gelatin 11.14. U.S. Flowable Hemostats Market Forecast, by End User 11.14.1. Hospitals 11.14.2. Clinics 11.14.3. Ambulatory Surgical Centers 11.15. Canada Flowable Hemostats Market Forecast, by Application 11.15.1. General Surgery 11.15.2. Cardiac Surgery 11.15.3. Vascular Surgery 11.15.4. Neuro & Spine Surgery 11.15.5. Orthopedic Surgery 11.15.6. Other Application 11.16. Canada Flowable Hemostats Market Forecast, by Components 11.16.1. Porcine Gelatin 11.16.2. Bovine Gelatin 11.17. Canada Flowable Hemostats Market Forecast, by End User 11.17.1. Hospitals 11.17.2. Clinics 11.17.3. Ambulatory Surgical Centers 11.18. North America Flowable Hemostats Market Attractiveness Analysis 11.18.1. by Components 11.18.2. by Application 11.18.3. by End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Flowable Hemostats Market Analysis 12.1. Key Findings 12.2. Europe Flowable Hemostats Market Overview 12.3. Europe Flowable Hemostats Market Value Share Analysis, by Application 12.4. Europe Flowable Hemostats Market Forecast, by Application 12.4.1. General Surgery 12.4.2. Cardiac Surgery 12.4.3. Vascular Surgery 12.4.4. Neuro & Spine Surgery 12.4.5. Orthopedic Surgery 12.4.6. Other Application 12.5. Europe Flowable Hemostats Market Value Share Analysis, by Components 12.6. Europe Flowable Hemostats Market Forecast, by Components 12.6.1. Porcine Gelatin 12.6.2. Bovine Gelatin 12.7. Europe Flowable Hemostats Market Value Share Analysis, by End User 12.8. Europe Flowable Hemostats Market Forecast, by End User 12.8.1. Hospitals 12.8.2. Clinics 12.8.3. Ambulatory Surgical Centers 12.9. Europe Flowable Hemostats Market Value Share Analysis, by Country 12.10. Europe Flowable Hemostats Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. Rest of Europe 12.11. Europe Flowable Hemostats Market Analysis, by Country 12.12. Germany Flowable Hemostats Market Forecast, by Application 12.12.1. General Surgery 12.12.2. Cardiac Surgery 12.12.3. Vascular Surgery 12.12.4. Neuro & Spine Surgery 12.12.5. Orthopedic Surgery 12.12.6. Other Application 12.13. Germany Flowable Hemostats Market Forecast, by Components 12.13.1. Porcine Gelatin 12.13.2. Bovine Gelatin 12.14. Germany Flowable Hemostats Market Forecast, by End User 12.14.1. Hospitals 12.14.2. Clinics 12.14.3. Ambulatory Surgical Centers 12.15. U.K. Flowable Hemostats Market Forecast, by Application 12.15.1. General Surgery 12.15.2. Cardiac Surgery 12.15.3. Vascular Surgery 12.15.4. Neuro & Spine Surgery 12.15.5. Orthopedic Surgery 12.15.6. Other Application 12.16. U.K. Flowable Hemostats Market Forecast, by Components 12.16.1. Porcine Gelatin 12.16.2. Bovine Gelatin 12.17. U.K. Flowable Hemostats Market Forecast, by End User 12.17.1. Hospitals 12.17.2. Clinics 12.17.3. Ambulatory Surgical Centers 12.18. France Flowable Hemostats Market Forecast, by Application 12.18.1. General Surgery 12.18.2. Cardiac Surgery 12.18.3. Vascular Surgery 12.18.4. Neuro & Spine Surgery 12.18.5. Orthopedic Surgery 12.18.6. Other Application 12.19. France Flowable Hemostats Market Forecast, by Components 12.19.1. Porcine Gelatin 12.19.2. Bovine Gelatin 12.20. France Flowable Hemostats Market Forecast, by End User 12.20.1. Hospitals 12.20.2. Clinics 12.20.3. Ambulatory Surgical Centers 12.21. Italy Flowable Hemostats Market Forecast, by Application 12.21.1. General Surgery 12.21.2. Cardiac Surgery 12.21.3. Vascular Surgery 12.21.4. Neuro & Spine Surgery 12.21.5. Orthopedic Surgery 12.21.6. Other Application 12.22. Italy Flowable Hemostats Market Forecast, by Components 12.22.1. Porcine Gelatin 12.22.2. Bovine Gelatin 12.23. Italy Flowable Hemostats Market Forecast, by End User 12.23.1. Hospitals 12.23.2. Clinics 12.23.3. Ambulatory Surgical Centers 12.24. Spain Flowable Hemostats Market Forecast, by Application 12.24.1. General Surgery 12.24.2. Cardiac Surgery 12.24.3. Vascular Surgery 12.24.4. Neuro & Spine Surgery 12.24.5. Orthopedic Surgery 12.24.6. Other Application 12.25. Spain Flowable Hemostats Market Forecast, by Components 12.25.1. Porcine Gelatin 12.25.2. Bovine Gelatin 12.26. Spain Flowable Hemostats Market Forecast, by End User 12.26.1. Hospitals 12.26.2. Clinics 12.26.3. Ambulatory Surgical Centers 12.27. Sweden Flowable Hemostats Market Forecast, by Application 12.27.1. General Surgery 12.27.2. Cardiac Surgery 12.27.3. Vascular Surgery 12.27.4. Neuro & Spine Surgery 12.27.5. Orthopedic Surgery 12.27.6. Other Application 12.28. Sweden Flowable Hemostats Market Forecast, by Components 12.28.1. Porcine Gelatin 12.28.2. Bovine Gelatin 12.29. Sweden Flowable Hemostats Market Forecast, by End User 12.29.1. Hospitals 12.29.2. Clinics 12.29.3. Ambulatory Surgical Centers 12.30. Rest of Europe Flowable Hemostats Market Forecast, by Application 12.30.1. General Surgery 12.30.2. Cardiac Surgery 12.30.3. Vascular Surgery 12.30.4. Neuro & Spine Surgery 12.30.5. Orthopedic Surgery 12.30.6. Other Application 12.31. Rest of Europe Flowable Hemostats Market Forecast, by Components 12.31.1. Porcine Gelatin 12.31.2. Bovine Gelatin 12.32. Rest of Europe Flowable Hemostats Market Forecast, by End User 12.32.1. Hospitals 12.32.2. Clinics 12.32.3. Ambulatory Surgical Centers 12.33. Europe Flowable Hemostats Market Attractiveness Analysis 12.33.1. by Components 12.33.2. by Application 12.33.3. by End User 12.34. PEST Analysis 12.35. Key Trends 12.36. Key Developments 13. Asia Pacific Flowable Hemostats Market Analysis 13.1. Key Findings 13.2. Asia Pacific Flowable Hemostats Market Overview 13.3. Asia Pacific Flowable Hemostats Market Value Share Analysis, by Application 13.4. Asia Pacific Flowable Hemostats Market Forecast, by Application 13.4.1. General Surgery 13.4.2. Cardiac Surgery 13.4.3. Vascular Surgery 13.4.4. Neuro & Spine Surgery 13.4.5. Orthopedic Surgery 13.4.6. Other Application 13.5. Asia Pacific Flowable Hemostats Market Value Share Analysis, by Components 13.6. Asia Pacific Flowable Hemostats Market Forecast, by Components 13.6.1. Porcine Gelatin 13.6.2. Bovine Gelatin 13.7. Asia Pacific Flowable Hemostats Market Value Share Analysis, by End User 13.8. Asia Pacific Flowable Hemostats Market Forecast, by End User 13.8.1. Hospitals 13.8.2. Clinics 13.8.3. Ambulatory Surgical Centers 13.9. Asia Pacific Flowable Hemostats Market Value Share Analysis, by Country 13.10. Asia Pacific Flowable Hemostats Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. Indonesia 13.10.7. Malaysia 13.10.8. Vietnam 13.10.9. ASEAN 13.10.10. Rest of Asia Pacific 13.11. Asia Pacific Flowable Hemostats Market Analysis, by Country 13.12. China Flowable Hemostats Market Forecast, by Application 13.12.1. General Surgery 13.12.2. Cardiac Surgery 13.12.3. Vascular Surgery 13.12.4. Neuro & Spine Surgery 13.12.5. Orthopedic Surgery 13.12.6. Other Application 13.13. China Flowable Hemostats Market Forecast, by Components 13.13.1. Porcine Gelatin 13.13.2. Bovine Gelatin 13.14. China Flowable Hemostats Market Forecast, by End User 13.14.1. Hospitals 13.14.2. Clinics 13.14.3. Ambulatory Surgical Centers 13.15. India Flowable Hemostats Market Forecast, by Application 13.15.1. General Surgery 13.15.2. Cardiac Surgery 13.15.3. Vascular Surgery 13.15.4. Neuro & Spine Surgery 13.15.5. Orthopedic Surgery 13.15.6. Other Application 13.16. India Flowable Hemostats Market Forecast, by Components 13.16.1. Porcine Gelatin 13.16.2. Bovine Gelatin 13.17. India Flowable Hemostats Market Forecast, by End User 13.17.1. Hospitals 13.17.2. Clinics 13.17.3. Ambulatory Surgical Centers 13.18. Japan Flowable Hemostats Market Forecast, by Application 13.18.1. General Surgery 13.18.2. Cardiac Surgery 13.18.3. Vascular Surgery 13.18.4. Neuro & Spine Surgery 13.18.5. Orthopedic Surgery 13.18.6. Other Application 13.19. Japan Flowable Hemostats Market Forecast, by Components 13.19.1. Porcine Gelatin 13.19.2. Bovine Gelatin 13.20. Japan Flowable Hemostats Market Forecast, by End User 13.20.1. Hospitals 13.20.2. Clinics 13.20.3. Ambulatory Surgical Centers 13.21. South Korea Flowable Hemostats Market Forecast, by Application 13.21.1. General Surgery 13.21.2. Cardiac Surgery 13.21.3. Vascular Surgery 13.21.4. Neuro & Spine Surgery 13.21.5. Orthopedic Surgery 13.21.6. Other Application 13.22. South Korea Flowable Hemostats Market Forecast, by Components 13.22.1. Porcine Gelatin 13.22.2. Bovine Gelatin 13.23. South Korea Flowable Hemostats Market Forecast, by End User 13.23.1. Hospitals 13.23.2. Clinics 13.23.3. Ambulatory Surgical Centers 13.24. Australia Flowable Hemostats Market Forecast, by Application 13.24.1. General Surgery 13.24.2. Cardiac Surgery 13.24.3. Vascular Surgery 13.24.4. Neuro & Spine Surgery 13.24.5. Orthopedic Surgery 13.24.6. Other Application 13.25. Australia Flowable Hemostats Market Forecast, by Components 13.25.1. Porcine Gelatin 13.25.2. Bovine Gelatin 13.26. Australia Flowable Hemostats Market Forecast, by End User 13.26.1. Hospitals 13.26.2. Clinics 13.26.3. Ambulatory Surgical Centers 13.27. Indonesia Flowable Hemostats Market Forecast, by Application 13.27.1. General Surgery 13.27.2. Cardiac Surgery 13.27.3. Vascular Surgery 13.27.4. Neuro & Spine Surgery 13.27.5. Orthopedic Surgery 13.27.6. Other Application 13.28. Indonesia Flowable Hemostats Market Forecast, by Components 13.28.1. Porcine Gelatin 13.28.2. Bovine Gelatin 13.29. Indonesia Flowable Hemostats Market Forecast, by End User 13.29.1. Hospitals 13.29.2. Clinics 13.29.3. Ambulatory Surgical Centers 13.30. Malaysia Flowable Hemostats Market Forecast, by Application 13.30.1. General Surgery 13.30.2. Cardiac Surgery 13.30.3. Vascular Surgery 13.30.4. Neuro & Spine Surgery 13.30.5. Orthopedic Surgery 13.30.6. Other Application 13.31. Malaysia Flowable Hemostats Market Forecast, by Components 13.31.1. Porcine Gelatin 13.31.2. Bovine Gelatin 13.32. Malaysia Flowable Hemostats Market Forecast, by End User 13.32.1. Hospitals 13.32.2. Clinics 13.32.3. Ambulatory Surgical Centers 13.33. Vietnam Flowable Hemostats Market Forecast, by Application 13.33.1. General Surgery 13.33.2. Cardiac Surgery 13.33.3. Vascular Surgery 13.33.4. Neuro & Spine Surgery 13.33.5. Orthopedic Surgery 13.33.6. Other Application 13.34. Vietnam Flowable Hemostats Market Forecast, by Components 13.34.1. Porcine Gelatin 13.34.2. Bovine Gelatin 13.35. Vietnam Flowable Hemostats Market Forecast, by End User 13.35.1. Hospitals 13.35.2. Clinics 13.35.3. Ambulatory Surgical Centers 13.36. ASEAN Flowable Hemostats Market Forecast, by Application 13.36.1. General Surgery 13.36.2. Cardiac Surgery 13.36.3. Vascular Surgery 13.36.4. Neuro & Spine Surgery 13.36.5. Orthopedic Surgery 13.36.6. Other Application 13.37. ASEAN Flowable Hemostats Market Forecast, by Components 13.37.1. Porcine Gelatin 13.37.2. Bovine Gelatin 13.38. ASEAN Flowable Hemostats Market Forecast, by End User 13.38.1. Hospitals 13.38.2. Clinics 13.38.3. Ambulatory Surgical Centers 13.39. Rest of Asia Pacific Flowable Hemostats Market Forecast, by Application 13.39.1. General Surgery 13.39.2. Cardiac Surgery 13.39.3. Vascular Surgery 13.39.4. Neuro & Spine Surgery 13.39.5. Orthopedic Surgery 13.39.6. Other Application 13.40. Rest of Asia Pacific Flowable Hemostats Market Forecast, by Components 13.40.1. Porcine Gelatin 13.40.2. Bovine Gelatin 13.41. Rest of Asia Pacific Flowable Hemostats Market Forecast, by End User 13.41.1. Hospitals 13.41.2. Clinics 13.41.3. Ambulatory Surgical Centers 13.42. Asia Pacific Flowable Hemostats Market Attractiveness Analysis 13.42.1. by Components 13.42.2. by Application 13.42.3. by End User 13.43. PEST Analysis 13.44. Key Trends 13.45. Key Developments 14. Middle East & Africa Flowable Hemostats Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Flowable Hemostats Market Overview 14.3. Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Application 14.4. Middle East & Africa Flowable Hemostats Market Forecast, by Application 14.4.1. General Surgery 14.4.2. Cardiac Surgery 14.4.3. Vascular Surgery 14.4.4. Neuro & Spine Surgery 14.4.5. Orthopedic Surgery 14.4.6. Other Application 14.5. Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Components 14.6. Middle East & Africa Flowable Hemostats Market Forecast, by Components 14.6.1. Porcine Gelatin 14.6.2. Bovine Gelatin 14.7. Middle East & Africa Flowable Hemostats Market Value Share Analysis, by End User 14.8. Middle East & Africa Flowable Hemostats Market Forecast, by End User 14.8.1. Hospitals 14.8.2. Clinics 14.8.3. Ambulatory Surgical Centers 14.9. Middle East & Africa Flowable Hemostats Market Value Share Analysis, by Country 14.10. Middle East & Africa Flowable Hemostats Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Flowable Hemostats Market Analysis, by Country 14.12. GCC Flowable Hemostats Market Forecast, by Application 14.12.1. General Surgery 14.12.2. Cardiac Surgery 14.12.3. Vascular Surgery 14.12.4. Neuro & Spine Surgery 14.12.5. Orthopedic Surgery 14.12.6. Other Application 14.13. GCC Flowable Hemostats Market Forecast, by Components 14.13.1. Porcine Gelatin 14.13.2. Bovine Gelatin 14.14. GCC Flowable Hemostats Market Forecast, by End User 14.14.1. Hospitals 14.14.2. Clinics 14.14.3. Ambulatory Surgical Centers 14.15. South Africa Flowable Hemostats Market Forecast, by Application 14.15.1. General Surgery 14.15.2. Cardiac Surgery 14.15.3. Vascular Surgery 14.15.4. Neuro & Spine Surgery 14.15.5. Orthopedic Surgery 14.15.6. Other Application 14.16. South Africa Flowable Hemostats Market Forecast, by Components 14.16.1. Porcine Gelatin 14.16.2. Bovine Gelatin 14.17. South Africa Flowable Hemostats Market Forecast, by End User 14.17.1. Hospitals 14.17.2. Clinics 14.17.3. Ambulatory Surgical Centers 14.18. Rest of Middle East & Africa Flowable Hemostats Market Forecast, by Application 14.18.1. General Surgery 14.18.2. Cardiac Surgery 14.18.3. Vascular Surgery 14.18.4. Neuro & Spine Surgery 14.18.5. Orthopedic Surgery 14.18.6. Other Application 14.19. Rest of Middle East & Africa Flowable Hemostats Market Forecast, by Components 14.19.1. Porcine Gelatin 14.19.2. Bovine Gelatin 14.20. Rest of Middle East & Africa Flowable Hemostats Market Forecast, by End User 14.20.1. Hospitals 14.20.2. Clinics 14.20.3. Ambulatory Surgical Centers 14.21. Middle East & Africa Flowable Hemostats Market Attractiveness Analysis 14.21.1. by Components 14.21.2. by Application 14.21.3. by End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Flowable Hemostats Market Analysis 15.1. Key Findings 15.2. South America Flowable Hemostats Market Overview 15.3. South America Flowable Hemostats Market Value Share Analysis, by Application 15.4. South America Flowable Hemostats Market Forecast, by Application 15.4.1. General Surgery 15.4.2. Cardiac Surgery 15.4.3. Vascular Surgery 15.4.4. Neuro & Spine Surgery 15.4.5. Orthopedic Surgery 15.4.6. Other Application 15.5. South America Flowable Hemostats Market Value Share Analysis, by Components 15.6. South America Flowable Hemostats Market Forecast, by Components 15.6.1. Porcine Gelatin 15.6.2. Bovine Gelatin 15.7. South America Flowable Hemostats Market Value Share Analysis, by End User 15.8. South America Flowable Hemostats Market Forecast, by End User 15.8.1. Hospitals 15.8.2. Clinics 15.8.3. Ambulatory Surgical Centers 15.9. South America Flowable Hemostats Market Value Share Analysis, by Country 15.10. South America Flowable Hemostats Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Flowable Hemostats Market Analysis, by Country 15.12. Brazil Flowable Hemostats Market Forecast, by Application 15.12.1. General Surgery 15.12.2. Cardiac Surgery 15.12.3. Vascular Surgery 15.12.4. Neuro & Spine Surgery 15.12.5. Orthopedic Surgery 15.12.6. Other Application 15.13. Brazil Flowable Hemostats Market Forecast, by Components 15.13.1. Porcine Gelatin 15.13.2. Bovine Gelatin 15.14. Brazil Flowable Hemostats Market Forecast, by End User 15.14.1. Hospitals 15.14.2. Clinics 15.14.3. Ambulatory Surgical Centers 15.15. Mexico Flowable Hemostats Market Forecast, by Application 15.15.1. General Surgery 15.15.2. Cardiac Surgery 15.15.3. Vascular Surgery 15.15.4. Neuro & Spine Surgery 15.15.5. Orthopedic Surgery 15.15.6. Other Application 15.16. Mexico Flowable Hemostats Market Forecast, by Components 15.16.1. Porcine Gelatin 15.16.2. Bovine Gelatin 15.17. Mexico Flowable Hemostats Market Forecast, by End User 15.17.1. Hospitals 15.17.2. Clinics 15.17.3. Ambulatory Surgical Centers 15.18. Rest of South America Flowable Hemostats Market Forecast, by Application 15.18.1. General Surgery 15.18.2. Cardiac Surgery 15.18.3. Vascular Surgery 15.18.4. Neuro & Spine Surgery 15.18.5. Orthopedic Surgery 15.18.6. Other Application 15.19. Rest of South America Flowable Hemostats Market Forecast, by Components 15.19.1. Porcine Gelatin 15.19.2. Bovine Gelatin 15.20. Rest of South America Flowable Hemostats Market Forecast, by End User 15.20.1. Hospitals 15.20.2. Clinics 15.20.3. Ambulatory Surgical Centers 15.21. South America Flowable Hemostats Market Attractiveness Analysis 15.21.1. by Components 15.21.2. by Application 15.21.3. by End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Vehicles 16.2.3.2. M&A Key Players, Forward Integration and BackwardIntegration 16.3. Company Profiles: Key Players 16.3.1. Johnson & Johnson 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Johnson & Johnson 16.3.3. Baxter International 16.3.4. Teleflex Incorporated 16.3.5. CR Bard, Inc. 16.3.6. Ethicon, Inc. 16.3.7. Braun Melsungen AG 16.3.8. Integra LifeSciences 16.3.9. Marine Polymer Technologies, Inc. 16.3.10. Pfizer, Inc. 16.3.11. Z-Medica LLC 17. Gelita Medical GmbH 18. Primary Key Insights